Search

everythinglearnresearchcommunity

for

Search:↓

The decision board effectively helps lupus nephritis patients in Brazil choose treatments by clearly presenting options and side effects.

Pembrolizumab can cause serious liver issues, requiring close monitoring and early treatment.

Switching Janus kinase inhibitors helped some patients with severe alopecia areata regrow hair, but insurance issues can worsen the condition.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

The ATAN-Met hydrogel helps heal infected diabetic wounds by promoting tissue regeneration and fighting bacteria.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

Ipilimumab can cause various adverse events in elderly patients, especially affecting the gastrointestinal and endocrine systems.

New drug uses show promise but need more research.

Exercise improves insulin sensitivity and hormone regulation in PCOS rats.

Lamotrigine may cause hair loss, affecting treatment compliance and health.

These new skin treatments are safer and more effective with minimal side effects.

More research is needed to understand the long-term benefits of insulin-sensitizing drugs for treating adolescents with PCOS.

Topical GT20029 effectively promotes hair regrowth and is well-tolerated.

SH-340 may improve skin barrier and help treat atopic dermatitis.

Certain medications can impact metabolic syndrome, with some improving conditions like high blood sugar and others having no effect.

Bicalutamide may help treat female pattern hair loss.

A low insulinemic diet improves weight, hormone levels, and well-being in women with PCOS.

Olumiant® (Baricitinib) is effective for treating hair loss from Alopecia Areata.

Topical Ruxolitinib may safely treat severe hair loss.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

Upadacitinib effectively treated severe hair loss in a child.

Oral difelikefalin significantly reduces itch in notalgia paresthetica.

GMG-43AC may help reduce unwanted hair growth and treat certain hair loss conditions.

Metformin is effective for treating excessive hair growth in women with PCOS and may work better than the standard treatment in some ways.

A 24-year-old man developed both alopecia areata universalis and type 1 diabetes at the same time, which is rare.

Tofacitinib might be used to treat hair loss.

Baricitinib stops hair loss and promotes regrowth in alopecia areata.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

Topical metformin helped regrow hair in two women with a hard-to-treat scarring hair loss condition.